Reorganization of Administrative Leadership in the Department

September 29, 2017

Appointments for new positions of Vice Chair of Research, Vice Chair of Clinical Services, and Chief of Staff.

Read more

Dr. Bruce Levine Appointed as Deputy Director of Technology Innovation at CCI

September 21, 2017

New role to coordinate the assessment and integration of new technologies into the continuum of new cellular therapies at the Center for Cellular Immunotherapies (CCI).

Read more

FDA Approves Personalized Cellular Therapy for Advanced Leukemia

August 30, 2017

Landmark decision for the field of cancer immunotherapy for first therapy based on gene transfer approved by the FDA.

Read more

First Atlas of B-cell Clones in Human Body for Infectious Disease Research

August 29, 2017

Prak Lab publishes “anatomic atlas” of B cells in Nature Biotechnology for research in infectious diseases, microbiome, vaccine responses, and tissue-specific immunity.

Read more

New Faculty Members in the Department for the Academic Year 2017-18

August 23, 2017

Specialty expertise in bioinformatics, genomic diagnostics, molecular therapeutics, neurogenetics, immunology, RNA biomarkers, RNA sequencing, clinical cytogenetics, placental pathology, and molecular neuropathology.

Read more

Penn-led Study Finds Retention of One Normal Version of BRCA Gene in Breast and Ovarian Cancers Influences Patient Survival

August 22, 2017

Analyses of BRCA1 and BRCA2 germline mutation-associated breast and ovarian tumors determines clinically useful biomarker to predict primary resistance to DNA damaging agents.

Read more

2017 CAP Inspection Concludes

August 11, 2017

College of American Pathologists summation report confirms the highest standards in quality, laboratory leadership, and day-to-day laboratory operations for the Department’s major anatomic and clinical pathology divisions.

Read more

Award for Dr. Doug Cines for Significant Contributions to Research and Education in Blood Coagulation

August 10, 2017

ISTH BACH Award for his exemplary models of research and mentoring excellence by International Society on Thrombosis and Haemostatis.

Read more

Pilot Study Tests CAR T-Cell Immunotherapy in Glioblastomas

July 20, 2017

Science Translational Medicine reports results of phase 1 safety study of autologous CAR T cells targeted to EGFR variant III in glioblastoma patients.

Read more

Pages